Additionally, the consistent result was also observed in the METABRIC dataset (http://www.cbioportal.org/), showing significantly higher RNF114 expression in HER2-positive BC compared to other subtypes (p=0.004) (Figure 2B). Here, ERBB2 is linked to breast cancer.